Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Quinidine Therapy for Lennox-Gastaut Syndrome With KCNT1 Mutation. A Case Report and Literature Review

5 Feb 2019

Abstract excerpt

Mutations in the Potassium channel subfamily T member 1 (KCNT1) gene have been reported in a range of epileptic encephalopathies. Here we report a case of a 12-year-old male suffering from multiple types of epileptic seizures and cognitive decline from the age of 10. The patient had four types of epileptic seizures, including tonic seizures, atypical absence seizures, myoclonic seizures and generalized...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Epilepsy research and treatment
Share to Ion channel regulation and function
Share to Ion Transport and Channel Regulation

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 30804880
DOI: 10.3389/fneur.2019.00064

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Quinidine Therapy for Lennox-Gastaut Syndrome With KCNT1 Mutation. A Case Report and Literature ReviewPMID 30804880Read ↗

New use for an old drug: quinidine in KCNT1-related epilepsy therapy.Semantic proximity Read ↗

Quinidine therapy for West syndrome with KCNTI mutation: A case report.Semantic proximity Read ↗

Precision therapy with quinidine of KCNT1-related epileptic disorders: A systematic review.Semantic proximity Read ↗

KCNT1-positive epilepsy of infancy with migrating focal seizures successfully treated with nonnarcotic antitussive drugs after treatment failure with quinidine: A case report.Semantic proximity Read ↗

Potassium channels and epilepsy.Semantic proximity Read ↗

Discovery of Potent and Selective Blockers Targeting the Epilepsy-Associated KNa1.1 Channel.Semantic proximity Read ↗

Early Treatment with Quinidine in 2 Patients with Epilepsy of Infancy with Migrating Focal Seizures (EIMFS) Due to Gain-of-Function KCNT1 Mutations: Functional Studies, Clinical Responses, and Critical Issues for Personalized Therapy.Semantic proximity Read ↗

Electrophysiological characterization of human KCNT1 channel modulators and the therapeutic potential of hydroquinine and tipepidine in KCNT1 mutation-associated epilepsy mouse model.Semantic proximity Read ↗

Therapeutic Drug Monitoring of Quinidine in Pediatric Patients with KCNT1 Genetic VariantsSemantic proximity Read ↗

KCNT1 mutations in seizure disorders: the phenotypic spectrum and functional effects.Semantic proximity Read ↗

Quinidine in the treatment of KCNT1-positive epilepsies.Semantic proximity Read ↗

A quinidine non responsive novel KCNT1 mutation in an Indian infant with epilepsy of infancy with migrating focal seizures.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.